In other innovation news, three Boston-area life sciences companies inked deals worth more than $200 million apiece:
Healthcare firm Alere acquired the toxicology screening company eScreen.
Boston Biomedical, a maker of cancer stem cell drugs, was acquired by Japan-based Dainippon Sumitomo Pharma.
And Concert Pharmaceuticals sold a worldwide license of its psychiatric drug to California-based Avanir Pharmaceuticals.
Meanwhile, India’s largest automaker, Tata Motors, has commissioned Watertown-based A123 Systems to supply the battery packs for its line of hybrid electric buses and other commercial vehicles. A123 has also begun rehiring the 125 employees it laid off last year.
The weekly roundup of business, technology and life science news from our partners at Xconomy.com airs every Friday on 89.7 Boston Public Radio.
Comment on This Article
From The World's Science podcast to Nova, we'll deliver updates from these cutting edge programs. See a sample »